Sex differences in vasopressin V₂ receptor expression and vasopressin-induced antidiuresis.
The renal vasopressin V(2) receptor (V(2)R) plays a critical role in physiological and pathophysiological processes associated with arginine vasopressin (AVP)-induced antidiuresis. Because clinical data suggests that females may be more prone to hyponatremia from AVP-mediated antidiuresis, we investigated whether there are sex differences in the expression and function of the renal V(2)R. In normal Sprague-Dawley rat kidneys, V(2)R mRNA and protein expression was 2.6- and 1.7-fold higher, respectively, in females compared with males. To investigate the potential physiological implications of this sex difference, we studied changes in urine osmolality induced by the AVP V(2)R agonist desmopressin. In response to different doses of desmopressin, there was a graded increase in urine osmolality and decrease in urine volume during a 24-h infusion. Females showed greater mean increases in urine osmolality and greater mean decreases in urine volume at 0.5 and 5.0 ng/h infusion rates. We also studied renal escape from antidiuresis produced by water loading in rats infused with desmopressin (5.0 ng/h). After 5 days of water loading, urine osmolality of both female and male rats escaped to the same degree physiologically, but V(2)R mRNA and protein in female kidneys was reduced to a greater degree (-63% and -73%, respectively) than in males (-32% and -48%, respectively). By the end of the 5-day escape period, renal V(2)R mRNA and protein expression were reduced to the same relative levels in males and females, thereby abolishing the sex differences in V(2)R expression seen in the basal state. Our results demonstrate that female rats express significantly more V(2)R mRNA and protein in kidneys than males, and that this results physiologically in a greater sensitivity to V(2)R agonist administration. The potential pathophysiological implications of these results are that females may be more susceptible to the development of dilutional hyponatremia because of a greater sensitivity to endogenously secreted AVP.
Division of Nephrology and Hypertension, Department of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA. jl225@georgetown.edu
Jun
J
Liu
Nikhil
N
Sharma
Wei
W
Zheng
Hong
H
Ji
Helen
H
Tam
Xie
X
Wu
Michaele B
MB
Manigrasso
Kathryn
K
Sandberg
Joseph G
JG
Verbalis
D000818:Animals; D050034:Antidiuretic Agents / Q000494:pharmacology; D051399:Aquaporin 2 / Q000378:metabolism; D001127:Arginine Vasopressin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology; D004231:Diuresis; D005260:Female; D006801:Humans; D007010:Hyponatremia / Q000378:metabolism; D008297:Male; D009994:Osmolar Concentration; D051381:Rats; D017483:Receptors, Vasopressin / Q000032:analysis / Q000378:metabolism*; D012737:Sex Factors; D014556:Urine / Q000737:chemistry
D050034:Antidiuretic Agents; D051399:Aquaporin 2; D017483:Receptors, Vasopressin; D001127:Arginine Vasopressin; D003894:Deamino Arginine Vasopressin